Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
fda
3
×
life sciences
national blog main
san diego blog main
3
×
san diego top stories
san francisco blog main
san francisco top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
3d imaging
alnylam pharmaceuticals
ambys medicines
amicus therapeutics
ampio pharmaceuticals
angelman syndrome
arena pharmaceuticals
athenex
biomarin pharmaceutical
biotech
bluebird bio
cancer
What
drug
3
×
patients
3
×
developers
fda
therapy
aren’t
bio
cancer
daunting
drugs
eisai
firms
flags
gene
healthcare
help
higher
imminent
incidence
long
lorcaserin
loss
market
marketing
markets
maze
medicare
medicine
mindmaze
moves
news
noteworthy
physical
policies
post
present
prices
probe
pulls
reflexion
Language
unset
Current search:
drug
×
patients
×
" san diego blog main "
×
fda
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
6 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
6 years ago
Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets